Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity
Andrew T. Vaughan, Chisako Iriyama, Stephen A. Beers, Claude H.T. Chan, Sean H. Lim, Emily L. Williams, Vallari Shah, Ali Roghanian, Bjorn Frendéus, Martin J. Glennie, Mark S. Cragg
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity'. Together they form a unique fingerprint.